e-learning
resources
Madrid 2019
Monday, 30.09.2019
Diagnostic procedures and biology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes
A. Raniszewska (Warsaw, Poland), H. Vroman (Rotterdam, Netherlands), D. Dumoulin (Rotterdam, Netherlands), J. Domagala-Kulawik (Warsaw, Poland), J. Aerts (Rotterdam, Netherlands)
Source:
International Congress 2019 – Diagnostic procedures and biology of lung cancer
Session:
Diagnostic procedures and biology of lung cancer
Session type:
Oral Presentation
Number:
1910
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Raniszewska (Warsaw, Poland), H. Vroman (Rotterdam, Netherlands), D. Dumoulin (Rotterdam, Netherlands), J. Domagala-Kulawik (Warsaw, Poland), J. Aerts (Rotterdam, Netherlands). Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes. 1910
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes
Source: ERJ Open Res, 3 (2) 00110-2016; 10.1183/23120541.00110-2016
Year: 2017
Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006
Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy
Source: Eur Respir J 2006; 28: Suppl. 50, 82s
Year: 2006
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy?
Source: Eur Respir J 2004; 24: Suppl. 48, 479s
Year: 2004
Lymph nodes frozen section in staging of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005
Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation
Source: Eur Respir J 2004; 24: Suppl. 48, 671s
Year: 2004
Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Human dendritic cells with PD-1+ CD80+ expression from lymph nodes aspirates of sarcoidosis patients.
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021
Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD
Source: Eur Respir J 2010; 35: 688-689
Year: 2010
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Detection of lung cancer micrometastases in lymph nodes aspirates by flow cytometry.
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept